Elliott R. M.

Dr. Elliott R. M. is a researcher at Deutsches Krebsforschungszentrum (DKFZ) in Heidelberg, Germany, specializing in radiation oncology with a focus on radiation-induced toxicity across multiple cancer types. As an active member of the international REQUITE Consortium, their work involves large-scale multi-center collaborations examining genetic and clinical predictors of treatment response.

Research interests include:

• Radiation-induced toxicity mechanisms and prediction
• Genetic polymorphisms associated with treatment response
• Patient-reported outcomes in cancer therapy
• Health-related quality of life following radiotherapy
• Cross-cancer analysis of radiation effects

Recent publications demonstrate a strong focus on developing predictive models for skin toxicity in breast cancer, analyzing professional-patient discrepancies in symptom assessment for lung cancer, and investigating genetic factors linked to radiation-induced acute toxicities across multiple cancer types through large-scale meta-GWAS studies.

Scientific contributions include:

• Multi-center studies involving thousands of patients
• Integration of genetic and clinical data for predictive modeling
• Analysis of circadian influences on radiotherapy side effects
• Examination of medication interactions with radiation toxicity

Dr. Elliott's work bridges clinical radiation oncology with genetic research, contributing to personalized approaches in cancer treatment that aim to minimize adverse effects while maintaining therapeutic efficacy. Their research within the REQUITE Consortium provides valuable real-world evidence for optimizing radiotherapy protocols across international settings.